The intrauterine exposure to hyperglycemia and placental methylation of leptin and adiponectin might lead to the development of leptin and insulin resistance and alter appetite circuits leading to postnatal hyperphagia, decreased satiety, and subsequent development of metabolic syndrome (Greco et al., 2019). Here, ADIPOQ is linked to metabolic syndrome.